Core Viewpoint - ST Yinjian (300020) reported a significant decline in both revenue and net profit for the third quarter of 2025, indicating potential financial distress and operational challenges [1] Financial Performance - The company achieved a revenue of 9.1585 million yuan in Q3 2025, representing a year-on-year decrease of 69.27% [1] - The net profit for the same period was -222.3 million yuan, reflecting a year-on-year decline of 125.36% [1]

Group 1 - ST Yinjian reported a revenue of approximately 131 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 76.01% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 544 million yuan [1] - The basic earnings per share showed a loss of 0.68 yuan [1] Group 2 - As of the report, ST Yinjian's market capitalization stands at 3 billion yuan [2]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 《银江技术股份有限公司 2025 年第三季度报告》已于 2025 年 10 月 29 日在 中国证监会指定的创业板信息披露网站上披露，请投资者注意查阅。 特此公告。 银江技术股份有限公司董事会 2025 年 10 月 29 日 证券代码：300020 证券简称：ST 银江 公告编号：2025-075 银江技术股份有限公司 2025 年第三季度报告披露提示性公告 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥9,158,518.18, a decrease of 69.27% compared to the same period last year[5] - The net profit attributable to shareholders was -¥222,572,770.82, representing a decline of 125.36% year-on-year[5] - The basic and diluted earnings per share were both -¥0.2800, down 125.26% from the previous year[5] - Total operating revenue for the current period is ¥130,655,079.18, a decrease of 76.0% compared to ¥544,623,089.55 in the previous period[21] - Net profit for the current period is a loss of ¥545,217,115.97, compared to a loss of ¥170,272,618.70 in the previous period, representing an increase in loss of 220.5%[22] - The company reported a total comprehensive loss of ¥545,217,115.97 for the current period, compared to a loss of ¥170,272,618.70 in the previous period[22] - Basic and diluted earnings per share for the current period are both -¥0.68, compared to -¥0.21 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,116,335,867.89, a decrease of 13.64% from the end of the previous year[5] - The equity attributable to shareholders decreased by 16.88% to ¥2,676,909,529.00 compared to the end of the previous year[5] - Total current assets decreased from ¥3,779,535,045.77 to ¥3,012,856,864.16, reflecting a decrease of approximately 20.3%[19] - Total assets decreased from ¥5,924,640,581.55 to ¥5,116,335,867.89, a decline of about 13.6%[20] - Total liabilities decreased from ¥2,683,058,181.18 to ¥2,419,970,583.49, a reduction of approximately 9.8%[20] - The company's total equity decreased from ¥3,241,582,400.37 to ¥2,696,365,284.40, reflecting a decline of about 16.8%[20] Cash Flow - Cash flow from operating activities showed a net outflow of -¥21,147,931.58, an increase of 83.84% in outflow compared to the previous year[5] - The net cash flow from operating activities is a negative ¥21,147,931.58, an improvement from a negative ¥130,882,521.80 in the previous period[24] - Cash and cash equivalents at the end of the period amount to ¥14,630,533.11, compared to ¥11,834,467.17 at the end of the previous period[25] - The company experienced a net cash outflow from investing activities of ¥12,757,144.06, compared to a net outflow of ¥281,249,404.73 in the previous period[24] - The net cash outflow from financing activities is ¥120,703,212.89, an improvement from a net outflow of ¥263,367,706.26 in the previous period[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,471[10] Expenses - Research and development expenses decreased due to the freezing of raised funds, impacting investment in projects[11] - Research and development expenses for the current period are ¥19,382,335.95, down 57.5% from ¥45,670,774.07 in the previous period[21] - The company experienced a reduction in sales expenses as a result of decreased revenue and lower sales input[11] Accounts Receivable and Inventory - Accounts receivable decreased from ¥1,319,171,415.29 to ¥1,066,749,357.80, a reduction of about 19.1%[19] - The company reported a significant increase in accounts receivable from ¥2,412,221.00 to ¥15,467,241.93, an increase of approximately 541.5%[19] - The company’s inventory decreased from ¥15,698,034.47 to ¥9,417,838.92, a decline of about 40.0%[19] Other Financial Issues - The company had a judicial freeze on its fundraising account totaling ¥133,301,636.20 due to litigation disputes[16] - The company reported a significant increase in credit impairment losses due to delayed project payments[11] - The company's cash and cash equivalents decreased from ¥431,799,252.67 to ¥217,941,565.02, representing a decline of approximately 49.6%[19] - The company's long-term equity investments decreased from ¥424,033,492.01 to ¥416,863,545.39, a reduction of approximately 1.7%[19]

证券代码：300020 证券简称：ST 银江 公告编号：2025-077 银江技术股份有限公司 第六届董事会第二十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 银江技术股份有限公司（以下简称"公司"或"银江技术"）第六届董事会 第二十五次会议于 2025 年 10 月 28 日在公司会议室以现场与通讯相结合的表决 方式召开，会议通知于 2025 年 10 月 22 日以直接送达或电话方式送达。会议应 参与表决董事 9 名，实际参与表决董事 9 名。本次会议的召开和表决符合《中华 人民共和国公司法》和《公司章程》等有关规定。 会议由代理董事长韩振兴先生主持，经与会董事讨论，通过如下决议： 一、审议通过《关于公司<2025 年第三季度报告>的议案》 经审议，全体董事一致认为：公司《2025 年第三季度报告》的编制和审核 的程序符合相关法律法规，报告内容真实、准确、完整地反映了公司 2025 年第 三季度经营的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 本议案在提交董事会审议前已经公司董事会审计委员会 2025 年第五次会议 审议通过。 ...

Group 1: Market Performance - The family doctor concept index rose by 1.38%, ranking 6th among concept sectors, with 17 stocks increasing in value [1] - Notable gainers included Haixia Innovation, which hit a 20% limit up, and other stocks like Heren Technology, ST Yinjian, and Zhujiang Shares, which rose by 5.00%, 3.88%, and 3.52% respectively [1] - The biggest decliners were Weining Health, Fosun Pharma, and Focus Technology, which fell by 2.85%, 2.05%, and 1.21% respectively [1] Group 2: Capital Flow - The family doctor concept sector saw a net inflow of 163 million yuan, with 10 stocks receiving net inflows, and 7 stocks attracting over 10 million yuan [2] - The top stock for net inflow was Keda Xunfei, with a net inflow of 155 million yuan, followed by China Ping An, Meian Health, and Haixia Innovation with net inflows of 142 million yuan, 50.97 million yuan, and 26.50 million yuan respectively [2] - In terms of capital inflow ratios, ST Yinjian, Huaping Shares, and Zhujiang Shares led with net inflow rates of 15.37%, 10.55%, and 10.31% respectively [3] Group 3: Individual Stock Performance - Keda Xunfei had a daily increase of 1.46% with a turnover rate of 3.29% and a net capital flow of 154.67 million yuan [3] - China Ping An showed a minimal increase of 0.02% with a net capital flow of 141.56 million yuan [3] - Haixia Innovation experienced a significant rise of 19.97% with a turnover rate of 20.34% and a net capital flow of 26.50 million yuan [3]

Group 1 - The core point of the article is the resignation of Wang Ningdan, the Deputy General Manager and Board Secretary of ST Yinjian, due to personal reasons, effective immediately after his resignation [1] - ST Yinjian's revenue for the year 2024 is entirely derived from the information technology services sector, accounting for 100% of its business [1] - As of the report date, ST Yinjian has a market capitalization of 2.9 billion yuan [1]

银江技术股份有限公司 证券代码：300020 证券简称：ST 银江 公告编号：2025-074 联系地址：浙江省杭州市西湖区西园八路 2 号 邮编：310030 关于公司副总经理、董事会秘书辞职的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 银江技术股份有限公司（以下简称"公司"）董事会于 2025 年 10 月 24 日 收到公司副总经理、董事会秘书王宁丹先生提交的书面辞职报告。王宁丹先生因 个人原因，申请辞去公司副总经理、董事会秘书职务，辞职后不再担任公司及子 公司任何职务。王宁丹先生的辞职报告自送达公司董事会之日起生效。 王宁丹先生担任公司副总经理、董事会秘书职务的原定任期为 2025 年 8 月 8 日 至 2025 年 11 月 23 日第六届董事会届满之日止。截至本公告披露日，王宁丹先生未 持有公司股份，不存在应当履行而未履行的承诺事项。王宁丹先生将继续严格遵守中 国证监会《上市公司董事、监事和高级管理人员所持本公司股份及其变动管理规则》 与《深圳证券交易所上市公司自律监管指引第 10 号——股份变动管理》的等相关法 律法规的规定。 王宁丹 ...

Group 1 - The ongoing investor compensation case against Silver River Technology (银江技术) is being actively pursued, with multiple filings submitted to the court, and the legal team is accepting additional claims from other investors [1] - Silver River Technology has been found guilty of several violations, including failure to disclose non-operating fund occupation by related parties and significant omissions in financial reports from 2018 to 2023 [1] - Investors who purchased Silver River Technology shares between April 19, 2019, and April 30, 2024, and sold or held the shares after April 30, 2024, may initiate compensation claims based on the violations identified [1] Group 2 - Yangzi New Materials (扬子新材) has received an administrative penalty from the China Securities Regulatory Commission (CSRC) for significant omissions in its annual report, including undisclosed related party fund occupations [2] - The company also faced accusations of false reporting, with approximately 137 million yuan in inflated revenue reported in 2020, which constituted about 11% of the total reported revenue for that year [4] - Investors who bought Yangzi New Materials shares between April 29, 2019, and December 30, 2022, and sold or held the shares after December 30, 2022, are eligible to file compensation claims based on the identified violations [4]

Core Points - ST Yinjian (stock code: 300020) held its 24th meeting of the 6th Board of Directors on October 15, 2025, where several important resolutions were passed [1] - The meeting was attended by 7 out of 9 directors, with 2 absent due to business trips, and was chaired by Chairman Han Zhenxing [1] Group 1 - The first resolution involved the amendment of the company's articles of association, which will be revised in accordance with relevant laws and regulations, and requires shareholder approval [1] - The second resolution pertained to the revision of the Board of Directors' meeting rules, which also requires shareholder approval [1] - The third resolution was to convene the 5th extraordinary general meeting of shareholders in 2025, which was approved unanimously [2]